Su Jin Lee Assistant Professor
College of Medicine
- Esther Building #1105
Research Record
- A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13) European Journal of Cancer, 2023, v.193, 113312
- A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer Cancer research and treatment, 2022, v.54 no.3, 719-727
- Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial Genome Medicine, 2022, v.14 no.1
- Detection of Fusion Genes Using a Targeted RNA Sequencing Panel in Gastrointestinal and Rare Cancers JOURNAL OF ONCOLOGY, 2020, v.2020, 4659062
- Synergistic Effects of Combination Therapy with AKT and mTOR Inhibitors on Bladder Cancer Cells INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, v.21 no.8, 2825
- Clinical significance of radiotherapy before and/or during nivolumab treatment in hepatocellular carcinoma CANCER MEDICINE, 2019, v.8 no.16, 6986-6994
- Comprehensive molecular and clinical characterization of Asian melanoma patients treated with anti-PD-1 antibody BMC CANCER, 2019, v.19 no.1, 805
- LAG3 in Solid Tumors as a Potential Novel Immunotherapy Target JOURNAL OF IMMUNOTHERAPY, 2019, v.42 no.8, 279-283
Courses
-
2024-1st
-
Clinical case studiesⅠ
- Subject No 37638Class No 01
- 3Year ( 1Credit , 15Hour)
- Major Requisite
-
Internal Medicine Clerkship Ⅳ
- Subject No 37644Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
Comprehensive Evaluation of Clinical Medicine Ⅰ
- Subject No 37667Class No 01
- 4Year ( 1Credit , 24Hour)
- Major Requisite
-
-
2023-2nd
-
Hematology and Oncology
- Subject No 37624Class No 01
- 2Year ( 3Credit , 65Hour)
- Major Requisite
-
Internal Medicine Clerkship Ⅳ
- Subject No 37644Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
Clinical case studiesⅡ
- Subject No 37659Class No 01
- 3Year ( 1Credit , 15Hour)
- Major Requisite
-
-
2023-1st
-
Clinical case studiesⅠ
- Subject No 37638Class No 01
- 3Year ( 1Credit , 15Hour)
- Major Requisite
-
Internal Medicine Clerkship Ⅳ
- Subject No 37644Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
Comprehensive Evaluation of Clinical Medicine I
- Subject No 37667Class No 01
- 4Year ( 1Credit , 24Hour)
- Major Requisite
-
-
2022-2nd
-
Hematology and Oncology
- Subject No 37624Class No 01
- 2Year ( 3Credit , 65Hour)
- Major Requisite
-
Problem-Based Learning Ⅱ(PBLⅡ)
- Subject No 37632Class No 01
- 2Year ( 1Credit , 15Hour)
- Major Requisite
-
Internal Medicine Clerkship Ⅳ
- Subject No 37644Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
Clinical case studiesⅡ
- Subject No 37659Class No 01
- 3Year ( 1Credit , 15Hour)
- Major Requisite
-
-
2022-1st
-
Internal Medicine Clerkship Ⅳ
- Subject No 37644Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
Comprehensive Evaluation of Clinical Medicine I
- Subject No 37667Class No 01
- 4Year ( 1Credit , 24Hour)
- Major Requisite
-
-
2021-2nd
-
Hematology and Oncology
- Subject No 37624Class No 01
- 2Year ( 3Credit , 65Hour)
- Major Requisite
-
Problem-Based Learning Ⅱ(PBLⅡ)
- Subject No 37632Class No 01
- 2Year ( 1Credit , 15Hour)
- Major Requisite
-
Internal Medicine Clerkship Ⅳ
- Subject No 37644Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
-
2021-1st
-
Internal Medicine Clerkship Ⅳ
- Subject No 37644Class No 01
- 3Year ( 4Credit , 220Hour)
- Major Requisite
-
Comprehensive Evaluation of Clinical Medicine I
- Subject No 37667Class No 01
- 4Year ( 1Credit , 24Hour)
- Major Requisite
-